1887

Abstract

CVI988 (Rispens), an avirulent strain of Marek's disease virus, is the most widely used vaccine against Marek's disease. The kinetics of replication of CVI988 was examined in tissues of chickens vaccinated at either 1 day or 14 days of age and sampled regularly up to 28 days post-vaccination. Age at vaccination had no significant effect on the kinetics of CVI988 virus replication. During the cytolytic phase of infection (1–7 days), virus levels peaked in the spleen, bursa and thymus with very close correlation among these organs. Virus load in peripheral blood lagged behind and did not reach high levels. Significant numbers of virus genomes were detected in the feather tips only after 7 days, but subsequently rose to levels almost 10-fold greater than in the other tissues. This is the first accurate quantitative data for kinetics of CVI988 replication in a variety of tissues. There was good correlation between data from virus isolation and PCR, with real-time PCR being the preferred method for rapid, accurate and sensitive quantification of virus. Feathers were ideal for non-invasive sampling to detect and measure CVI988 in live chickens and, from 10 days onwards, virus load in feather tips was predictive of virus load in lymphoid tissues where immune responses will occur. The potential for real-time PCR analysis of feather samples for further investigation of the mechanism of vaccinal protection, and to assist optimization of vaccination regimes, is discussed.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.81299-0
2005-11-01
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/jgv/86/11/2989.html?itemId=/content/journal/jgv/10.1099/vir.0.81299-0&mimeType=html&fmt=ahah

References

  1. Baaten B. J., Butter C., Davison T. F. 2004; Study of host–pathogen interactions to identify sustainable vaccine strategies to Marek's disease. Vet Immunol Immunopathol 100:165–177 [CrossRef]
    [Google Scholar]
  2. Baigent S. J., Davison F. 1999; Development and composition of lymphoid lesions in the spleens of Marek's disease virus-infected chickens: association with virus spread and the pathogenesis of Marek's disease. Avian Pathol 28:287–300 [CrossRef]
    [Google Scholar]
  3. Baigent S. J., Davison T. F. 2004; Marek's disease virus: biology and life cycle. In Marek's Disease: an Evolving Problem pp  62–77 Edited by Davison F., Nair V. Oxford: Elsevier;
    [Google Scholar]
  4. Baigent S. J., Ross L. J. N., Davison T. F. 1996; A flow cytometric method for identifying Marek's disease virus pp38 expression in lymphocyte sub-populations. Avian Pathol 25:255–267 [CrossRef]
    [Google Scholar]
  5. Baigent S. J., Ross L. J. N., Davison T. F. 1998; Differential susceptibility to Marek's disease is associated with differences in number, but not phenotype or location, of pp38+ lymphocytes. J Gen Virol 79:2795–2802
    [Google Scholar]
  6. Baigent S. J., Petherbridge L. J., Howes K., Smith L. P., Currie R. J. W., Nair V. K. 2005; Absolute quantitation of Marek's disease virus genome copy number in chicken feather and lymphocyte samples using real-time PCR. J Virol Methods 123:53–64 [CrossRef]
    [Google Scholar]
  7. Beasley J. N., Paterson L. T., McWade D. H. 1970; Transmission of Marek's disease by poultry house dust and chicken dander. Am J Vet Res 31:339–344
    [Google Scholar]
  8. Becker Y., Asher Y., Tabor E., Davidson I., Malkinson M., Weisman Y. 1992; Polymerase chain reaction for differentiation between pathogenic and non-pathogenic serotype 1 Marek's disease viruses (MDV) and vaccine viruses of MDV-serotypes 2 and 3. J Virol Methods 40:307–322 [CrossRef]
    [Google Scholar]
  9. Becker Y., Tabor E., Asher Y., Davidson I., Malkinson M., Witter R. L. 1993; PCR detection of amplified 132 bp repeats in Marek's disease virus type 1 (MDV-1) DNA can serve as an indicator for critical genomic rearrangement leading to the attenuation of virus virulence. Virus Genes 7:277–287 [CrossRef]
    [Google Scholar]
  10. Bublot M., Sharma J. 2004; Vaccination against Marek's disease. In Marek's Disease: an Evolving Problem pp  168–185 Edited by Davison F., Nair V. Oxford: Elsevier;
    [Google Scholar]
  11. Buscaglia C., Calnek B. W., Schat K. A. 1988; Effect of immunocompetence on the establishment and maintenance of latency with Marek's disease herpesvirus. J Gen Virol 69:1067–1077 [CrossRef]
    [Google Scholar]
  12. Calnek B. W. 2001; Pathogenesis of Marek's disease virus infection. Curr Top Microbiol Immunol 255:25–55
    [Google Scholar]
  13. Calnek B. W., Adldinger H. K., Kahn D. E. 1970; Feather follicle epithelium: a source of enveloped and infectious cell-free herpesvirus from Marek's disease. Avian Dis 14:219–233 [CrossRef]
    [Google Scholar]
  14. Churchill A. E., Biggs P. M. 1967; Agent of Marek's disease in tissue culture. Nature 215:528–530 [CrossRef]
    [Google Scholar]
  15. Davidson I., Borenshtain R. 2003; Novel applications of feather tip extracts from MDV-infected chickens; diagnosis of commercial broilers, whole genome separation by PFGE and synchronic mucosal infection. FEMS Immunol Med Microbiol 38:199–203 [CrossRef]
    [Google Scholar]
  16. Davidson I., Borenshtain R., Weisman Y. 2002; Molecular identification of the Marek's disease virus vaccine strain CVI988 in vaccinated chickens. J Vet Med B Infect Dis Vet Public Health 49:83–87 [CrossRef]
    [Google Scholar]
  17. de Boer G. F., Groenendal J. E., Boerrigter H. M., Kok G. L., Pol J. M. 1986; Protective efficacy of Marek's disease virus (MDV) CVI-988 CEF65 clone C against challenge infection with three very virulent MDV strains. Avian Dis 30:276–283 [CrossRef]
    [Google Scholar]
  18. Fukuchi K., Tanaka A., Schierman L. W., Witter R. L., Nonoyama M. 1985; The structure of Marek disease virus DNA: the presence of unique expansion in nonpathogenic viral DNA. Proc Natl Acad Sci U S A 82:751–754 [CrossRef]
    [Google Scholar]
  19. Gimeno I. M., Witter R. L., Hunt H. D., Reddy S. M., Reed W. M. 2004; Biocharacteristics shared by highly protective vaccines against Marek's disease. Avian Pathol 33:59–68
    [Google Scholar]
  20. Handberg K. J., Nielsen O. L., Jorgensen P. H. 2001; The use of serotype 1- and serotype 3-specific polymerase chain reaction for the detection of Marek's disease virus in chickens. Avian Pathol 30:243–249 [CrossRef]
    [Google Scholar]
  21. Jeurissen S. H. M. 1991; Structure and function of the chicken spleen. Res Immunol 142:352–355 [CrossRef]
    [Google Scholar]
  22. Kaiser P., Underwood G., Davison F. 2003; Differential cytokine responses following Marek's disease virus infection of chickens differing in resistance to Marek's disease. J Virol 77:762–768 [CrossRef]
    [Google Scholar]
  23. Lee S. I., Ohashi K., Morimura T., Sugimoto C., Onuma M. 1999; Re-isolation of Marek's disease virus from T cell subsets of vaccinated and non-vaccinated chickens. Arch Virol 144:45–54 [CrossRef]
    [Google Scholar]
  24. Malkinson M., Davidson I., Strenger C., Weisman Y., Maray T., Levy H., Becker Y. 1989; Kinetics of the appearance of Marek's disease virus DNA and antigens in the feathers of chickens. Avian Pathol 18:735–744 [CrossRef]
    [Google Scholar]
  25. Maotani K., Kanamori A., Ikuta K., Ueda S., Kato S., Hirai K. 1986; Amplification of a tandem direct repeat within inverted repeats of Marek's disease virus DNA during serial in vitro passage. J Virol 58:657–660
    [Google Scholar]
  26. Morimura T., Ohashi K., Sugimoto C., Onuma M. 1998; Pathogenesis of Marek's disease (MD) and possible mechanisms of immunity induced by MD vaccine. J Vet Med Sci 60:1–8 [CrossRef]
    [Google Scholar]
  27. Parcells M. S., Arumugaswami V., Prigge J. T., Pandya K., Dienglewicz R. L. 2003; Marek's disease virus reactivation from latency: changes in gene expression at the origin of replication. Poult Sci 82:893–898 [CrossRef]
    [Google Scholar]
  28. Rispens B. H., Van Vloten J., Mastenbroek N., Maas H. J. L., Schat K. A. 1972; Control of Marek's disease in the Netherlands. I. Isolation of an avirulent Marek's disease virus (strain CVI 988) and its use in laboratory vaccination trials. Avian Dis 16:108–125 [CrossRef]
    [Google Scholar]
  29. Sacco M. A., Howes K., Smith L. P., Nair V. K. 2004; Assessing the roles of endogenous retrovirus EAV-HP in avian leukosis virus subgroup J emergence and tolerance. J Virol 78:10525–10535 [CrossRef]
    [Google Scholar]
  30. Sambrook J., Russell D. W. 2001 Molecular Cloning: a Laboratory Manual vol 1 Cold Spring Harbor, NY: Cold Spring Harbor Laboratory;
    [Google Scholar]
  31. Silva R. F. 1992; Differentiation of pathogenic and non-pathogenic serotype 1 Marek's disease viruses (MDVs) by the polymerase chain reaction amplification of the tandem direct repeats within the MDV genome. Avian Dis 36:521–528 [CrossRef]
    [Google Scholar]
  32. Silva R. F., Witter R. L. 1985; Genomic expansion of Marek's disease virus DNA is associated with serial in vitro passage. J Virol 54:690–696
    [Google Scholar]
  33. Silva R. F., Calvert J. G., Lee L. F. 1997; A simple immunoperoxidase plaque assay to detect and quantitate Marek's disease virus plaques. Avian Dis 41:528–534 [CrossRef]
    [Google Scholar]
  34. Silva R. F., Reddy S. M., Lupiani B. 2004; Expansion of a unique region in the Marek's disease virus genome occurs concomitantly with attenuation but is not sufficient to cause attenuation. J Virol 78:733–740 [CrossRef]
    [Google Scholar]
  35. Witter R. L. 1997; Increased virulence of Marek's disease virus field isolates. Avian Dis 41:149–163 [CrossRef]
    [Google Scholar]
  36. Witter R. L., Silva R. F., Lee L. F. 1987; New serotype 2 and attenuated serotype 1 Marek's disease vaccine viruses: selected biological and molecular characteristics. Avian Dis 31:829–840 [CrossRef]
    [Google Scholar]
  37. Witter R. L., Calnek B. W., Buscaglia C., Gimeno I. M., Schat K. A. 2005; Classification of Marek's disease viruses according to pathotype: philosophy and methodology. Avian Pathol 34:75–90 [CrossRef]
    [Google Scholar]
  38. Yunis R., Jarosinski K. W., Schat K. A. 2004; Association between rate of viral genome replication and virulence of Marek's disease herpesvirus strains. Virology 328:142–150 [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.81299-0
Loading
/content/journal/jgv/10.1099/vir.0.81299-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error